Press Releases.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
March 05, 2014- Study Designed to Demonstrate Human Proof-of-Concept Results by YE 2014 -
-
February 27, 2014- Achieved All Goals on 'Road to the Clinic'; Launched 'Clinical Map Initiative'-
-
February 19, 2014-RG-012 is an anti-miR Targeting microRNA-21 for the Treatment of Alport Syndrome, a Life-Threatening, Genetic Kidney Disease with No Approved Therapy-
-
February 13, 2014-Martin Beaulieu, Ph.D. Brings Extensive Diagnostic Assay Development Experience-
-
February 05, 2014-Regulus to Develop microRNA-21 for Alport Syndrome, a Life-Threatening Orphan Kidney Disease, and microRNA-21 in Oncology, to Human Proof-of-Concept-
-
February 04, 2014-Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience-